Human microsomal epoxide hydrolase: 5'-Flanking region genetic polymorphisms

Carcinogenesis

Volumn 19, Issue 3, 1998, Pages 387-393

  Raaka, Stuart ^a   Hassett, Christopher ^a   Omiecinski, Curtis J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA FRAGMENT; EPOXIDE HYDROLASE; MICROSOME ENZYME;

ARTICLE; CLONING VECTOR; DNA FLANKING REGION; DNA POLYMORPHISM; DNA SEQUENCE; DNA TRANSFECTION; GENE FREQUENCY; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR CLONING; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; REPORTER GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA FRAGMENTATION; EPOXIDE HYDROLASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE FREQUENCY; HUMANS; LINKAGE (GENETICS); MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); THYMIDINE KINASE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031927837     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.3.387     Document Type: Article

References (42)

1. Oesch, F. (1973) Mammalian epoxide hydrases: Inducible enzymes catalyzing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica, 3, 305-340.
2. Sims, P., Grover, P.L., Swaisland, A., Pal, K. and Hewer, A. (1974) Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature, 252, 326-328.
3. Oesch, F., Glatt, H. and Schimassmann, H. (1977) The apparent ubiquity of epoxide hydratase in rat organs. Biochem. Pharmacol., 26, 603-607.
4. Seidegard, J. and DePierre, J.W. (1983) Microsomal epoxide hydrolase. Properties, regulation and function. Biochim. Biophys. Acta. 695, 251-270.
5. Omiecinski, C.J., Aicher, L., Holubkov, R. and Checkoway, H. (1993) Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics, 3, 150-158.
6. Etter, H., Richter, C., Ohta, Y., Winterhalter, K.H., Sasabe, H. and Kawato, S. (1991) Rotation and interaction with epoxide hydrase of cytochrome P-450 in proteoliposomes. J. Biol. Chem., 266, 18600-18605.
7. Vogel-Bindel, U., Bentley, P. and Oesch, F. (1982) Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate. Eur. J. Biochem., 126, 425-431.
8. Hassett, C., Tumblom, S.M., DeAngeles, A. and Omiecinski, C.J. (1989) Rabbit microsomal epoxide hydrolase: isolation and characterization of the xenobiotic metabolizing enzyme cDNA. Arch. Biochem. Biophys., 271, 380-389.
9. Mertes, I., Fleischmann, R., Glatt, H.R. and Oesch, F. (1985) Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver. Carcinogenesis, 6, 219-223.
10. Seidegard, J., DePierre, J.W. and Pero, R.W. (1984) Measurement and characterisation of membrane-bound and soluble epoxide hydrolase activities in resting mononuclear leucocytes from human blood. Cancer Res., 44, 3654-3660.
11. Strickler, S.M., Dansky, L.V., Miller, M.A. et al. (1985) Genetic predisposition to phenytoin-induced birth defects. Lancet, 2, 746-749.
12. Buehler, B.A., Delimont, D., van-Waes, M. and Finnell, R.H. (1990) Prenatal prediction of risk of the fetal hydantoin syndrome. N. Engl. J. Med., 322, 1567-1572.
13. Spielberg, S.P. (1980) Acetaminophen toxicity in human lymphocytes in vitro. J. Pharmacol. Exp. Ther., 213, 395-398.
14. Spielberg, S.P., Gordon, G.B., Blake, D.A., Goldstein, D.A. and Herlong, H.F. (1981) Predisposition to phenytoin hepatotoxicity assessed in vitro. N. Engl. J. Med., 305, 722-729.
15. Gaedigk, A., Spielberg, S.P. and Grant, D.M. (1994) Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics, 4, 142-153.
16. Green, V.J., Pirmohamed, M., Kitteringham, N.R., Gaedigk, A., Grant, D.M., Boxer, M., Burchell, B. and Park, B.K. (1995) Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. Biochem. Pharmacol., 50, 1353-1359.
17. Davis, C.D., Pirmohamed, M., Kitteringham, N.R., Allott, R.L., Smith, D. and Park, B.K. (1995) Kinetic parameters of lymphocyte microsomal epoxide hydrolase in carbamazepine hypersensitive patients. Assessment by radiometric HPLC. Biochem. Pharmacol., 50, 1361-1366.
18. Heckbert, S.R., Weiss, N.S., Hornung, S.K., Eaton, D.L. and Motulsky, A.G. (1992) Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. Natl Cancer Inst., 84, 414-422.
19. McGlynn, K.A., Rosvold, E.A., Lustbader, E.D., et al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc. Natl. Acad. Sci., 92, 2384-2387.
20. Lancaster, J.M., Brownlee, H.A., Bell, D.A., Futreal, P.A., Marks, J.R., Berchuck, A., Wiseman, R.W. and Taylor, J.A. (1996) Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol. Carcinogen., 17, 160-162.
21. Hassett, C., Aicher, L., Sidhu, J.S. and Omiecinski, C.J. (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet., 3, 421-428.
22. Hayashi, S., Watanabe, J. and Kawajiri, K. (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P-450 IIE1 gene. J. Biochem., 110, 559-565.
23. Jeenah, M., Kessling, A., Miller, N. and Humphries, S. (1990) G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol. Biol. Med., 7, 233-241.
24. Dammerman, M., Sandkuijl, L.A., Halaas, J.L., Chung, W. and Breslow, J.L. (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc. Natl Acad. Sci., 90, 4562-4566.
25. Song, Z., Casolaro, V., Chen, R., Georas, S., Monos, D. and Ono, S. (1996) Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J. Immunol., 156, 424-429.
26. Checkoway, H., Costa, L.G., Camp, J., Coccini, T., Daniell, W.E. and Dills, R.L. (1992) Peripheral markers of neurochemical function among workers exposed to styrene. Br. J. Ind. Med., 49, 560-565.
27. Wilson, N.M. and Omiecinski, C.J. (1989) Xenobiotic microsomal epoxide hydrolase: 5′ sequence of the human gene. Biochim. Biophys. Acta, 1008, 357-358.
28. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. and Sekiya, T. (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl Acad. Sci., 86, 2766-2270.
29. Gibbs, R., Nguyen, P. and Caskey, C. (1989) Detection of single base differences by competitive oligonucleotide priming. Nucl. Acids Res., 17, 2437-2448.
30. Iyer, R.R. (1991) A matched set of cat vectors for rapid mutational analysis of eukaryotic promoters and enhancers. Gene. 105, 97-100.
31. Lee, S.Y. and Rasheed, S. (1990) A simple procedure for maximum yield of high quality plasmid DNA. Biotechniques, 9, 676-679.
32. Felgner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M. and Danielson, M. (1987) Lipofectin: a highly efficient lipid mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA, 84, 7413-7417.
33. Berger, J., Hauber, J., Hauber, R., Geiger, R. and Cullen, B.R. (1988) Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene, 66, 1-10.
34. Vogel, F. and Kopun, M. (1977) Higher frequencies of transitions among point mutations. J. Mol. Evol., 9, 159-180.
35. Cooper, D.N., Smith, B.A., Cooke, H.J., Niemann, S. and Schmidtke, J. (1985) An estimate of unique DNA sequence heterozygosity in the human genome. Hum. Genet., 69, 201-205.
36. Hassett, C., Robinson, K.B., Beck, N.B. and Omiecinski, C.J. (1994) The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics, 23, 433-442.
37. Vogel, F. and Motulsky, A.G. (1986) Human Genetics: Problems and Approaches, 2nd edn. Springer Verlag, Berlin.
38. Powers, P.A. and Smithie, O. (1986) Short gene conversion in the human fetal globin gene region: a by-product of chromosome pairing during meiosis? Genetics, 112, 343-358.
39. Boulikas, T. (1994) A compilation and classification of DNA binding sites for protein transcription factors from vertebrates. Crit. Rev. Eukaryot. Gene Expr., 4, 117-321.
40. Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. (1995) MatInd and MatInspector-New, fast, and versatile tools for detection of consensus matches in nucleotide sequence data. Nucl. Acids Res., 23, 4878-4884.
41. Courtois, S.J., Lafontaine, D.A., Lemaigre, F.P., Durviaux, S.M. and Rousseau, G.G. (1990) Nuclear factor-1 and activator protein-2 bind in a mutually exclusive way to overlapping promoter sequences and transactivate the human growth hormone gene. Nucl. Acids Res., 18, 57-64.
42. Hassett, C., Lin, J., Carty, C.L., Laurenzana, E.M. and Omiecinski, C.J. (1996) Human hepatic microsomal epoxide hydrolase: Comparative analysis of polymorphic expression. Arch. Biochem. Biophys., 337, 275-283.